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From food to fertilizer, algal derived products are largely employed in assorted industries, including agricultural, biomedical, food,
and pharmaceutical industries. Among different chemical compositions isolated from algae, polysaccharides are the most well-
established compounds, which were subjected to a variety of studies due to extensive bioactivities. Over the past few decades,
the promising results for antiviral potential of algae-derived polysaccharides have advocated them as inordinate candidates for
pharmaceutical research. Numerous studies have isolated various algal polysaccharides possessing antiviral activities, including
carrageenan, alginate, fucan, laminaran, and naviculan. In addition, different mechanisms of action have been reported for these
polysaccharides, such as inhibiting the binding or internalization of virus into the host cells or suppressing DNA replication and
protein synthesis.This review strives for compiling previous antiviral studies of algae-derived polysaccharides and theirmechanism
of action towards their development as natural antiviral agents for future investigations.
1. Introduction
Distinctive structure of viruses and their complicated life
cycle have made the discovery of definite treatments against
antiviral infections extremely demanding. Despite compre-
hensive studies for suitable vaccines and treatments against
viral infections over the past half of a century, still several
infections, such as human immunodeficiency virus (HIV),
hepatitis C virus (HCV), and dengue virus (DENV), afflict
a substantial proportion of the world populations in all
generations [1–3]. Vaccine development against some viruses
such as HIV and HCV was so far proved to be an intractable
approach and there is no definite vaccine against numerous
prevalent viral infections, including most respiratory-tract
viruses, herpesviruses (HSV-1 andHSV-2), and human papil-
loma viruses (HPVs). Moreover, drug resistance to available
antiviral agents by different viruses such as HIV type 1 (HIV-
1) has always been a serious impediment to treatment of
viral infections [4]. Until the 21st century, approximately
less than only ten drugs were officially licensed against
viral infections. Since then, better understanding of viral
proliferation cycle and numerous researches have marked a
quantum leap forward in the discovery of new antiviral drugs
[5]. Nonetheless, despite some very real gains, we are still far
more away from controlling the viral infections.
The unique living environment has gifted the marine
world an assorted collection of algae from microorganisms
to giant seaweeds. Various types of algae from microscopic
diatoms to unicellular organisms and seaweeds reaching
30m in length have stimulated significant economic interest
as agar, fertilizer, food, source of iodine, and potash [6].
Amongst marine natural products, approximately 9% of
biomedical compounds have been isolated from algae [7].
These marine organisms can synthetize assorted types of
metabolisms, including polysaccharides, chlorophyll, ace-
togenins, fatty acids, vitamins, xanthophylls, amino acids,
and halogenated compounds [8–11]. Despite being underex-
ploited plant resources, recent investigations have established
algae as a rich arsenal of active metabolites with pharmaceu-
tical potential, including anticancer, antitumor, antioxidant,
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antiobesity, neuroprotective, antimicrobial, antinociceptive,
anti-inflammatory, and antiangiogenic activities [8, 12–16].
2. Algae-Derived Polysaccharides
Polysaccharides, also known as glycans, are the most abun-
dant form of carbohydrate materials in the nature. Due to
marked biological activities, numerous studies have been per-
formed on different algae-derived polysaccharides, namely,
agar, alginate, fucoidan, carrageenan, laminaran, proteogly-
cans, galactosyl glycerol, and rhamnan sulfate [9, 17–20].
The algae polysaccharides are natural polymers that are
easily available in nature, nontoxic, cheap, safe, biodegrad-
able, and biocompatible [21]. These polysaccharides have
gained interesting and wide applications in the biomedical
and pharmaceutical industries. Depending on the source of
isolation, structure of some polysaccharides such as fucoidan
can differ in the nature of constituents and the amount
and length of their branching chains [22]. However, new
synthetic routes are aiming to modify the biological activities
of these polysaccharides through chemical modification and
combination with other polymers [23].
3. Antiviral Activity of Algal Polysaccharides
A study by Gerber and colleagues in 1958 which showed
inhibition ofmumps and influenzaB virus by polysaccharides
from marine algae has introduced algae-derived polysaccha-
rides as a potent source of antiviral agents [24]. Subsequently,
antiviral activities of other polysaccharide fractions isolated
from red algae have been reported against HSV and other
viruses in the next two decades. Since then, numerous studies
have published antiviral potential of various algae-derived
polysaccharides and their underlying mechanism of action
[25–28].This review tries to summarize the antiviral activities
of algae-derived polysaccharides and themechanisms under-
lying these activities (see Table 1).
3.1. Carrageenan. Carrageenans are naturally occurring ani-
onic sulfated polysaccharides (SPs), which appear as matrix
material in great quantities by certain red algae (Rhodophy-
ta), such as Chondrus, Gigartina, Hypnea, and Eucheuma,
wherein they serve a structural function similarity to that of
cellulose in plants [29]. The existence of 3,6-anhydrogalac-
topyranose and allocation of the sulfate groups on the main
structures naturally classify carrageenan into three kinds, 𝜆-,
𝜅-, and 𝜄-carrageenan (Figure 1) [30], and individually display
special antiviral effects on several viral agents [31].
Carrageenans are selective inhibitors of several enveloped
and nonenveloped viruses and act predominantly by inhibit-
ing the binding or internalization of virus into the host
cells [32, 33]. Carrageenans are exceptionally potent inhibitor
of HPV in vitro by inhibiting the initial stage of infec-
tion [32]. Notably, they are also extremely effective against
a range of sexually transmitted HPV types that lead to
cervical cancer and genital warts [34, 35]. Carlucci and
colleagues found that 𝜆-type carrageenan is active against
the replication of HSV upon its firm interaction that leads
to inactivation of HSV virion [36]. They also discovered that
the 𝜆-carrageenan and moderately cyclized 𝜇/𝜄-carrageenan
isolated from Gigartina skottsbergii exert promising antiviral
activities towards diverse strains of HSV-1 and HSV-2 during
virus attachment stage [37, 38]. Surprisingly, similar results
were reported by different group of researchers, who analysed
the chemical structure and antiviral activity of carrageenan
(lambda, kappa, and iota) against HSV-2 infection [39,
40]. A recent in vitro study conducted by Grassauer and
colleagues reported the inhibitory effects of 𝜄-carrageenan
against human rhinovirus (HRV) proliferation by preventing
the primary phases of virus replication. They have suggested
that this effect is possibly attributed to the suppression of the
allosteric activity of virus particles during their entry [33].
Additionally, 𝜄-carrageenan was proven to be effective against
dengue virus replication in mosquito and mammalian cells;
however, themode of antiviral action of 𝜄-carrageenan in both
cell types was interestingly distinctive. In Vero cell line, the
inhibitory activity has been exerted at early stage of virus
adhesion probably due to some primary receptors, whereas
in mosquito cell it affected the cell proliferation and protein
synthesis [41, 42].
A recent in vivo study in mice has revealed that the
low molecular weight carrageenans (3, 5, and 10 kDa), as
well as acetylated and sulfated derivatives, have substantial
inhibitory effects against influenza virus. Furthermore, the
smallest 𝜅-carrageenan with appropriate sulfation and acety-
lation degree was the greatest antiviral candidate against
influenza virus in vivo [43]. Yamada and colleagues remarked
the fact that the antiviral activities of carrageenans are
extremely correlated with their molecular weights and exis-
tence of sulfation groups, since different molecular weightO-
acylated carrageenans reduced the HIV activity by depoly-
merisation and sulfation process [44].
3.2. Galactan. The main extracellular polysaccharides of red
algae are known as sulfated galactans. They are made up of
linear chains of galactoses with a few exceptions; a chain
of alternating 3-𝛽-D-galactopyranose (G units) and 4-𝛼-D-
galactopyranose residues or 4-3,6-anhydrogalactopyranose
residues complete their structural backbone with presence of
D-series (D unit) in carrageenans and L-series (L unit) in
agarans (Figure 2) [45, 46]. Another exceptional collection
of galactans also exists: the DL-hybrids that enclose G unit
attached to both D and L units [47, 48].
The various structural types of these polysaccharides have
shown a vigorous antiviral potency against several enveloped
viruses, such as HSV-1 and HSV-2, DENV, HIV-1 and HIV-2,
and hepatitis A virus [49, 50]. Three galactan polysaccharide
fractions from the Argentinian marine alga Callophyllis var-
iegatawere isolated and purified by Rodr´ıguez and colleagues
in 2005. In addition to the structural illustration of main
fractions, the antiviral effect of these fractions was assessed
against HSV-1 and HSV-2 and DENV-2, which surprisingly
exhibited potent inhibitory effects with low cytotoxicity
together. Therefore, it was suggested that these compounds
might develop “promising antiviral agents” [51]. It was also
reported that galactan sulfate (GS), isolated from Agardhiella
tenera, displays an effective control against HIV-1 and HIV-2.
GS blocked the adhesion of virus to cell, in addition to
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Table 1: Antiviral activities of algae polysaccharides derived from marine sources.
Antiviral polysaccharide Organism Virus
Carrageenan Red alga, Gigartina skottsbergii Influenza virus, DENV, HSV-1, HSV-2, HPV,HRV, HIV
Galactan
Red algae, Callophyllis variegate, Agardhiella
tenera, Schizymenia binderi, Cryptonemia
crenulata
HSV-1, HSV-2, HIV-1, HIV-2, DENV, HAV
Alginate
Brown algae, Laminaria hyperborea, Laminaria
digitata, Laminaria japonica, Ascophyllum
nodosum,Macrocystis pyrifera
HIV, IAV, HBV
Fucan
Brown algae, Adenocytis utricularis, Undaria
pinnatifida, Stoechospermum marginatum,
Cystoseira indica, Cladosiphon okamuranus, Fucus
vesiculosus
HSV-1, HSV-2, HCMV, VSV, Sindbis virus, HIV-1
Laminaran Brown algae, Fucus vesiculosus, Saccharinalongicruris, Ascophyllum nodosum HIV
Naviculan Diatom, Navicula directa HSV-1, HSV-2
p-KG03 Microalga, Gyrodinium impudicum EMCV, influenza A virus
A1 and A2 Microalga, Cochlodinium polykrikoides Influenza A and B viruses, RSV-A, RSV-B,parainfluenza-2
Calcium spirulan Blue-green alga, Arthrospira platensis HSV-1, measles, mumps, influenza, polio,Coxsackie, HIV-1, HCMV
Nostaflan Blue-green alga, Nostoc flagelliforme HSV-1, HSV-2, influenza A virus, humancytomegalovirus
Sea algae extract Red alga, Schizymenia pacifica HIV, AMV, RMLV
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Figure 1: Chemical structure of carrageenan units, namely, kappa,
lambda, and iota, isolated from red seaweeds.
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the attachment of gp120 on CD4+ T cell receptor to HIV-
1 gp120. Consistently, GS at the concentration of >5 g/L
blocked syncytia emergence in Molt-4 cells and HIV-1 or
HIV-2 infected HUT-78 cells [49]. Matsuhiro and Colleagues
discovered the antiviral property of a sulfated galactan iso-
lated from the marine red seaweed Schizymenia binderi by
reviewing its structural configuration. This sulfated galactan
clearly presented highly selective antiviral effect against HSV
types 1 and 2 with lowest cytotoxicity. Its inhibitory effects are
suggested to be involved in the attachment of virus to host
cells [52]. Moreover, Talarico and colleagues examined the
antiviral activity of a D,L-galactan hybrid C2S-3, extracted
from the Brazilian marine alga Cryptonemia crenulata, in
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Figure 3: Chemical structure of alginate polysaccharide (GM blocks).
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Figure 4: Chemical structure of sulfated polymannuroguluronate (SPMG).
the multiplication of DENV-2 in Vero cell line. As this
compound lacked any cytotoxicity to Vero cell line, it is
indicated that it is effective against three clinical strains of
DENV-2 (IC
50
= 0.8–16 𝜇g/mL). Further mechanistic work
concluded that the compound affects the initial steps of virus
adsorption and entry into the host cells; therefore C2S-3 is
supported to be a “promisingDENV-2 antientry” as well [53].
3.3. Alginate. Alginates are the principle cell wall acidic
polysaccharides widely distributed in brown algae (Phaeo-
phyceae) including Laminaria hyperborea, Laminaria digi-
tata, Laminaria japonica, Ascophyllum nodosum, andMacro-
cystis pyrifera.They are mostly extracted from bubble Zoster-
aceae, kelp, macro algae, and marjoram algae, respectively.
Alginates are linear anionic polysaccharides, composed of
a main backbone of poly-D-glucuronic acid (G blocks)
and poly-D-mannuronic acid (M blocks), together with D-
guluronic acid and D-mannuronic acid (GM blocks) usually
alternating (Figure 3) [54, 55]. Alginates have found numer-
ous applications in biomedical science and engineering and
have been particularly attractive for their antiviral activities.
A prominent marine polysaccharide drug named 911
derived from alginate polysaccharide exhibited promising
activity against HIV-1 at both chronic infection of H9 cells
and acute infection of MT4 cells in vitro and in vivo.
These special effects revealed that 911 drug inhibited the
viral replication of HIV via significantly decrementing the
activity of reverse transcriptase (RTase), discontinuing the
virus adsorption, and improving the defense mechanisms
of the host cells [56, 57]. Alternative inhibitory result was
also reported later for hepatitis B virus (HBV) that 911 drug
could inhibit the virus replication by suppressing the activity
of DNA polymerase activity [58]. Wang and colleagues
discovered that the sulfated polymannuroguluronate (SPMG)
(Figure 4) [55], the sulfated formof alginate, is a characteristic
anti-AIDS drug candidate, as it caused the inhibition of
HIV-1 infection mainly through the robust attachment of
virus gp120 protein with CD4 molecules on the surface of
T cells. Moreover, there is huge correlation between the size
of SPMG oligosaccharides and their inhibitory significance
that the octasaccharide will be the minimal active fragment
preventing syncytium formation and reducing the P24 core
antigen level in HIV-IIIB-infected CEM cells [59, 60].
3.4. Fucan and Fucoidan. Fucans are high molecular weight
sulfated polysaccharides, usually classified into three major
groups: glycuronogalactofucans, fucoidans, and xylofucogly-
curonans. These polymers occur in the intercellular tissues
or mucilaginous matrix of brown algae. They are widely
distributed in the cell walls of brown algae and regarded
only as a huge source of L-fucose with different portions
of neutral sugars such as galactose, glucose, mannose, and
uronic acid that can occur in the polymer [61]. Fucose is
attached to the central backbone, mainly bound by 1 → 2
glycosidic linkages, forming branching points at every 2-3
fucose residues within the chain [62]. The structure of algal
fucans varies among species and sometimes among different
kinds of the seaweed [63, 64]. Fucans have a broad spectrum
of biological activities. However, the structure of algal fucans
varies among species and sometimes among different parts of
the seaweed [63, 64]. Thus, each new purified sulfated fucan
is a unique compound and thus a potential new drug.
Beside many other well-attested responsibilities, such
antiproliferative, antiadhesive effects on cells can especially
protect the cells from viral infections [65]. Queiroz and
colleagues evidence that the sulfated fucans from such sea-
weed species Dictyota mertensii, Lobophora variegata, Fucus
vesiculosus, and Spatoglossum schroederi could prevent HIV
infection via blocking the activity of reverse transcriptase
and notably their results strongly indicated the necessity of
sulfate and carboxyl group in the inhibitory activity of these
polysaccharides [66]. A fucan polysaccharide isolated from
Cladosiphon okamuranus with glucuronic acid and sulfated
fucose units’ composition inhibited DENV-2 infection in
BHK-21 cell line. Conversely, less effect was observed on three
other serotypes of DENV (DENV-1, DENV-3, and DENV-
4) [67]. Further investigation of the envelope glycoprotein
compositions from the existing four serotypes of DENV
revealed that arginine-323 inDENV-2 plays an important role
upon its interaction with the fucan and content of sulfation of
BioMed Research International 5
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Figure 5: Chemical structures of two different backbones for fucoidan. R groups demonstrate potential places for attachment of carbohydrate
(𝛼-L-fucopyranose and 𝛼-D-glucuronic acid) and noncarbohydrate (sulfate and acetyl groups) substituents.
fucan was also vital for this activity [45]. Akamatsu and col-
leagues evaluated an effective anti-influenza virus compound
named MC26, a new type of fucose polysaccharides isolated
from marine brown algae species, Sargassum piluliferum. It
exhibited a stronger anti-influenza virus activity with low
cytotoxicity in vivo and in vitro as compared with known
active compounds [68]. Furthermore,Mandal and colleagues
studied the sulfated fucans extracted from brown seaweed
Cystoseira indica, which exhibited a promising activity against
HSV-1 and HSV-2 deprived of any cytotoxicity for Vero cell
cultures; however no direct inactivating effect on virions in a
virucidal assay was detected. Hence, it was suggested that the
mode of action of these compounds could be possibly due to
the inhibition of virus adsorption [69].
Fucoidan is a term used to define a polysaccharide
based mainly on sulfated L-fucose and less than 10% on
other monosaccharides. The term sulfated fucan can be
used to define heterofucans containing sulfated fucose and
neutral sugars. However, fucans and fucoidans are often
used interchangeably. Fucoidan has a high proportion of
fucose in the extracellular matrix of several brown algae
such as mozuku, komby, limu moui, bladderwrack, wakame,
hijiki, and sea cucumber. The main skeleton of fucoidans
involves a-1,3-linked sulfated L-fucose, a repeating sequence
of alternating a-(1-3)- with the possible a-(1-4)-glycosidic
bonds. The chemical structure and composition of fucoidans
are considerably diverse, depending highly on the isolated
species, which usually are sulfated and acetylated and may
also hold uronic acid (Figure 5) [70–72].
Fucoidan possesses various biological activities such
as activity against many RNA and DNA viruses both in
vivo and in vitro, including important human pathogens
such as HIV, HSV1-2, dengue virus, and cytomegalovirus
[67, 73]. Fucoidans demonstrated their antiviral activities
by mainly blocking the interaction of viruses to the cells
so as to inhibit viral-induced syncytium formation [74].
Isolated fucoidans from several species,Adenocytis utricularis
[75], Undaria pinnatifida (Mekabu) [76], Stoechospermum
marginatum [77],Undaria pinnatifida [78, 79], andCystoseira
indica [69], exhibited potential antiviral effects against HSV-1
and HSV-2 deprived of cytotoxicity for Vero cell cultures.
Elizondo-Gonzalez and colleagues reported that the iso-
lated fucoidan from Cladosiphon okamuranus showed potent
antiviral activity against Newcastle disease virus in the Vero
cell line at the initial stages of infection. The viral-induced-
syncytial formation declined by exposure of fucoidan prior
to cleavage of the fusion protein, which led to attachment of
fucoidan to the F0 protein. Consequently, fucoidan exhibited
a better antiviral potency than ribavirin [80]. Moen and
Clark, 1993, studied isolated fucoidan from F. vesiculosus,
which showed its potential to suppress HIV RT in vitro.
Unexpectedly, preincubation of cell-free virus to 200mg/mL
caused 100% diminution in the amount of HIV-1 p24 antigen
release. These studies showed that respective activities are
not because of dispatching of target cells. Indeed, fucoidan
induced no adverse effects on protein metabolism and cell
generation.HIV-1 infection of target cells is actually protected
after preincubation with fucoidan. Moreover, fucoidan can
effectively augment immune system health by activating
immunoreactions of the cellular and humoral types and by
increasing macrophage phagocytosis [62, 81]. In conclusion,
fucoidan directly affects the secretion of extracellular matrix
proteins, influences the proliferation of cells, and can activate
apoptosis [82–85].
3.5. Laminaran. Laminaran, a glucan, is one of the com-
mon polysaccharides abundant in a wide variety of brown
algae such as F. vesiculosus, Saccharina longicruris, and
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Ascophyllum nodosum. It is a linear polysaccharide made up
of 𝛽-(1 → 3)-linked glucose in the central chain, with 𝛽-
(1 → 6)-linked side-chain branching (Figure 6) [30, 86].Thus
far, two kinds of laminaran are recognized: one kind is made
of glucose residues (G-series), whereas the other kind is ter-
minated by D-mannitol residues (M-series) [87]. Therefore,
the ratios of the two kinds of laminaran, together with their
structural configurations, are changeable according to the
isolated species, as well as environmental factors predicted to
directly affect the biological properties of laminaran [88, 89].
Laminaran is created by photosynthesis and exhibits a great
antiviral activity and low toxicity in vivo [90]. Muto and
colleagues reported that laminaran polysaccharides extracted
from kelp are proficient to prevent the activity of HIV
by preventing the adsorption of HIV on human-derived
lymphocytes and the ability of HIV reverse transcriptase,
which play an important role for the virus proliferation. This
study suggested that laminaran polysaccharides are effective
inhibitors on HIV replication and proliferation [91].
3.6. Naviculan. Naviculan is a sulfated polysaccharide from
a diatom called Navicula directa. This compound is made
of several sugars such galactose, xylose, rhamnose, fucose
mannose, and sulphate with a high molecular weight. Lee
and colleagues reported that naviculan has a potent antiviral
activity against HSV-1 and HSV-2 (IC
50
: 7–14𝜇g/mL) and
influenza virus by inhibiting the initial stages of viral repli-
cation, possibly blocking viral internalization into host cells.
Moreover, naviculan displayed a notable inhibitory effect on
fusion between the cells that express CD4 receptor and HIV
gp160-expressing HeLa cell line, which was used as a model
system of HIV infection. This study proposed naviculan as a
novel antiviral sulfated polysaccharide with a wide range of
activities against enveloped viruses [92].
3.7. p-KG03. The marine microalga Gyrodinium impudicum
strain KG03 produces a highly sulfated exopolysaccharide
p-KG03. The p-KG03 polysaccharide is unique compound
with the molecular weight of 1.87 × 107, categorized as a
homopolysaccharide of galactose conjugatedwith uronic acid
and sulfate groups. P-KG03 was the first reported marine
compound to impressively suppress tumor cell growth and
infection by encephalomyocarditis virus (EMCV) in vitro
(EC
50
= 26.9 𝜇g/mL). It was shown that the development
of cytopathic effects in HeLa cells infected by EMCV was
either suppressed entirely or reduced by differing the p-
KG03 concentration [93]. Moreover, Kim and colleagues
reported that the p-KG03 exhibits great inhibitory activity
on influenza A virus infection but not all influenza B viruses
in vitro. This study highlighted that the virus replication was
declined when p-KG03 was added throughout the infection
activity, meaning that these compounds mainly target the
viral adsorption and internalization steps. Accordingly, the
polysaccharide p-KG03 not only is capable of preventing
the attachment of influenza virus to host cells but also
blocks the cellular internalization of the virus and early
stages of replication.Hence, the potential activities of p-KG03
evidenced that the sulfated metabolites from marine systems
could be a possible candidate for drug development [94].
3.8. A1 and A2. Extracellular sulfated polysaccharides A1 and
A2 are found inmarine microalga, Cochlodinium polykrikoid-
es. These polysaccharides are constituted of glucose, galac-
tose, mannose, and uronic acid, with distribution of sulfate
groups. The cytopathogenic effects of HIV- 1 in MT-4 cells,
influenza virus types A and B inMDCK cells, and respiratory
syncytial virus types A and B in Hep-2 cells were inhibited
by A1 and A2. It was approved that A1 polysaccharides are
also effective against HSV-1, whilst A2 polysaccharides are
effective against parainfluenza virus type 2, both in HMV-2
cell line. Both A1 and A2 polysaccharides are noncytotoxic
at 100 𝜇g/mL and generate weak (10%) inhibitory effects on
blood coagulation at specific concentrations that cause viral
inhibition [95].
3.9. Calcium Spirulan. A novel sulfated polysaccharide,
termed calcium spirulan (Ca-SP), was isolated from amarine
blue-green alga, Arthrospira platensis (previously called Spir-
ulina platensis).This polysaccharide is found to be composed
of mannose, ribose, fructose, glucose, xylose, galactose,
rhamnose, galacturonic acid, glucuronic acid, calcium, and
sulfate. Hayashi and colleagues in 1996 found Ca-SP to be
the selective inhibitor of various viruses, including HSV-1 (in
HeLa cells), HCMV (in HEL cells), influenza A (in MDCK
cells), Coxsackie virus (in Vero cells), measles (in Vero cells),
HIV-1 (in MT-4 cells), polio (in Vero cells), and mumps (in
Vero cells). This study revealed that the antiviral activities
of Ca-SP are attributed to inhibition of virus entry into host
cells and Ca-SP was also shown to have a small anticoagulant
activity [96]. Lastly, Hayashi and colleagues expanded their
discoveries by comparing the anti-HIV-1 and anti-HSP-1
activities of Ca-SP with antiviral effects of dextran sulfate
(DS) as a symbolic sulfated polysaccharide.Their results indi-
cated that Ca-SP is an applicable antiviral compound against
both HSV-1 and HIV-1. Therefore, Ca-SP became known
as a relatively promising anti-HIV polysaccharide since, at
low concentrations of Ca-SP, formation of virus-induced
syncytium did not happen. More importantly, presence of
calcium was found to be pivotal for dose-dependent suppres-
sion of syncytium formation and cytopathic effect induced by
HIV-1. In conclusion, by overcoming the drawbacks reported
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for other sulfated polysaccharides, Ca-SP can be a promising
candidate for development of new anti-HIV drugs [96].
3.10. Nostoflan. Nostoflan (NSF) is an acidic polysaccharide
found in edible blue-green alga, Nostoc flagelliforme. The
structural analyses of NSF revealed that it is mainly made of
sugar sequences of (→ 4)-𝛽-d-Glcp-(1 → 4)-d-Xylp-(1 and
→ 4)-[𝛽-d-GlcAp-(1 → 6)-]-𝛽-d-Glcp-(1 → 4)-d-Galp-
(1→ ). Kanekiyo and colleagues identified that nostoflan has a
noble inhibitory effect on several enveloped viruses including
HSV-1 and HSV-2, human cytomegalovirus, and influenza
A virus. The most sensitive stage of viral replication to
nostoflan in time of addition during experiment was assumed
to be the initial stage of infection covering the virus binding
or/and internalization processes. But further investigation
confirmed that uniquely the inhibition of virus binding to
host cells was responsible for the antiherpetic effect induced
by nostoflan and their findings recommended nostoflan as a
great antiherpes candidate [97].
3.11. Sea Algae Extract. Sea algae extract (SAE) is a sulfated
polysaccharide with the high molecular weight isolated from
marine red alga Schizymenia pacifica. SAE is a member
of 𝜆-carrageenan, which is composed of galactose (73%),
sulfonate (20%), and 3,6-anhydrogalactose (0.65%), and it
is known that SEA is a selective inhibitor of HIV reverse
transcriptase and replication in vitro and has no adverse effect
on cell proliferation [98]. Similar results are obtained once
a cell-free system was employed to examine the effect of
SEA on reverse transcriptase from avian retrovirus (avian
myeloblastosis virus) and mammalian retrovirus (Rauscher
murine leukemia virus). The SEA exhibited inhibitory effects
on reverse transcriptase of both retroviruses but elicited no
effects on the function of cellular DNA polymerase alpha
and RNA polymerase II in vitro. Accordingly, it is unlikely
to have an adverse effect on the proliferation of cell culture.
It is hypothesized that sulfate residues play a vital role in
RT suppression activity. This hypothesis is substantiated by
inducing activity in polysaccharides [99].
4. Conclusions
Avariety of biological activities are reported for algal polysac-
charides including the transcendent antiviral effect. In the
majority of cases, the antiviral activity of these polysaccha-
rides is exerted through suppression of virus adhesion to the
host cells. Throughout our literature review, it was noticed
that despite numerous investigations which substantiated the
antiviral potential of algal polysaccharides, few aspects may
have been neglected by researchers to date. Many of the
reported pharmacological studies were only limited to in
vitro investigation in a single host cells. However, in vivo
examination is pivotal for the development of pharmaceutical
drugs. In addition, further studies including clinical trials to
exploit the antiviral activity against viral infections in human
are another area for further research. To the best of our
knowledge, the synergistic activity of algal polysaccharides
against viral infections was not adequately covered in previ-
ous studies. It is hoped that this review would be a source of
enlightenment and motivation for the interested researchers
to conduct further in vitro, in vivo, and clinical analyses on
the antiviral activity of algal polysaccharides with a view to
developing new antiviral drugs.
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